RE:Potential RiseI did own SESN for a while and then sold. May have a few hundred still left. In TLTs case, the anticipation will be AA after BTD, so hoping any spike will sustain itself. Curious to see what happens with IBRX. Their next decision from the FDA is expected around May, I think.
enriquesuave wrote: I remember about 4 years ago when SESN bio went from 0.60 to over $3 ( from February to May a gradual increase) in anticipation of preliminary 90 days data readout on about 55 patients. The anticipation was to see if doubling the number of treatments from 1 per week to 2 instillations per week would increase efficacy seen in PH2 of 40% at 90 days. It didn't and no increase in efficacy was noted, and SP went down gradually to around $1. Can we see the same happen here but go even higher on favourable data?